INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Total Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹87 Cr | ₹73 Cr | ₹60 Cr | ₹47 Cr | ₹38 Cr |
What is the latest Total Current Assets ratio of INDO US BIOTECH ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹87 Cr |
| Mar2024 | ₹73 Cr |
| Mar2023 | ₹60 Cr |
| Mar2022 | ₹47 Cr |
| Mar2021 | ₹38 Cr |
How is Total Current Assets of INDO US BIOTECH Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹87 Cr | 18.66 | |
| Mar2024 | ₹73 Cr | 22.00 | |
| Mar2023 | ₹60 Cr | 27.31 | |
| Mar2022 | ₹47 Cr | 23.40 | |
| Mar2021 | ₹38 Cr | - | |
Compare Total Current Assets of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹225.3 Cr | -1.9% | -9% | -53.1% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,089.0 Cr | -6.1% | -9% | -14.4% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,131.8 Cr | -9.7% | -13.7% | -8.6% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,048.0 Cr | -6.5% | 3.4% | -15.2% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹972.4 Cr | -6.9% | -7.9% | -32.7% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹413.3 Cr | 4.1% | -14.6% | -12.3% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -1.9% |
-9% |
-53.1% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses